BusinessActinium Pharmaceuticals to Present at 30th Annual ROTH ConferenceBy Nasdaq OMXMar 7, 2018, 12:30 PM UTC
BusinessActinium Pharmaceuticals Highlights Key Activities and Progress at BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 28, 2018, 12:30 PM UTC
BusinessActinium Pharmaceuticals Announces Commencement of Rights Offering Subscription PeriodBy Nasdaq OMXFeb 22, 2018, 12:31 PM UTC
BusinessCognoa Hits Major Milestone Towards First AI-Based Autism DiagnosticBy Nasdaq OMXFeb 21, 2018, 2:04 PM UTC
BusinessActinium Pharmaceuticals Announces Product Showcase and Other Visibility Extending Activities at the BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant OrganizationsBy Nasdaq OMXFeb 20, 2018, 12:30 PM UTC
BusinessPacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional AnalgesiaBy Nasdaq OMXFeb 15, 2018, 8:34 PM UTC
BusinessActinium Announces Submission of IND For Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AMLBy Nasdaq OMXFeb 12, 2018, 9:15 PM UTC
BusinessBioCorRx Extends Service Agreement with Dr. Balbir S. Brar as VP of Drug Development Following Pre-IND Meeting with the U.S. FDABy Nasdaq OMXFeb 8, 2018, 12:31 PM UTC
